WILLIAM J. BURTIS, M.D., Ph.D.; TERENCE L. WU, B.S.; KARL L. INSOGNA, M.D.; ANDREW F. STEWART, M.D.
This content is PDF only. Please click on the PDF icon to access.
At the Annual Meeting of the American Society for Bone and Mineral Research last June, three groups announced the isolation and amino-acid sequencing of a protein that appears to be responsible for humoral hypercalcemia of malignancy (HHM) (1-4). Isolation of the protein, the cloning of the cDNA that encodes it and the resultant elucidation of the full-length amino-acid sequence of the HHM-factor (5, 6) cap years of steady progress in this field and have implications that extend beyond the syndrome of humoral hypercalcemia of malignancy. It is timely to review the clinical syndrome as well as its history and pathophysiology,
BURTIS WJ, WU TL, INSOGNA KL, STEWART AF. Humoral Hypercalcemia of Malignancy. Ann Intern Med. ;108:454–457. doi: 10.7326/0003-4819-108-3-454
Download citation file:
Published: Ann Intern Med. 1988;108(3):454-457.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use